Cargando…
Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center
The COVID-19 pandemic strained healthcare systems worldwide, delaying breast cancer screening and surgery. In 2019, approximately 80% of breast cancers in the U.S. were diagnosed on screening examinations, with 76.4% of eligible Medicare patients undergoing screening at least every two years. Since...
Autores principales: | Diskin, Brian, Pourkey, Nakisa, Schnabel, Freya, Miah, Pabel, DiMaggio, Charles, Axelrod, Deborah, Shapiro, Richard, Guth, Amber A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275681/ https://www.ncbi.nlm.nih.gov/pubmed/37334101 http://dx.doi.org/10.1155/2023/6278236 |
Ejemplares similares
-
Clinical Characteristics in Patients with Triple Negative Breast Cancer
por: Yeh, Janet, et al.
Publicado: (2017) -
Breast Cancer Profile among Patients with a History of Chemoprevention
por: Schnabel, Freya R., et al.
Publicado: (2016) -
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ()
por: Darvishian, Farbod, et al.
Publicado: (2022) -
SAS for Epidemiologists: Applications and Methods
por: DiMaggio, Charles
Publicado: (2013) -
Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same
por: Friedman, Erica B., et al.
Publicado: (2013)